TY - JOUR
T1 - Generating Virtual Patients by Multivariate and Discrete Re-Sampling Techniques
AU - Teutonico, D.
AU - Musuamba Tshinanu, Flora
AU - Maas, H. J.
AU - Facius, A.
AU - Yang, S.
AU - Danhof, M.
AU - Della Pasqua, O.
N1 - Publisher Copyright:
© 2015 The Author(s).
PY - 2015/10/26
Y1 - 2015/10/26
N2 - Purpose: Clinical Trial Simulations (CTS) are a valuable tool for decision-making during drug development. However, to obtain realistic simulation scenarios, the patients included in the CTS must be representative of the target population. This is particularly important when covariate effects exist that may affect the outcome of a trial. The objective of our investigation was to evaluate and compare CTS results using re-sampling from a population pool and multivariate distributions to simulate patient covariates. Methods: COPD was selected as paradigm disease for the purposes of our analysis, FEV1 was used as response measure and the effects of a hypothetical intervention were evaluated in different populations in order to assess the predictive performance of the two methods. Results: Our results show that the multivariate distribution method produces realistic covariate correlations, comparable to the real population. Moreover, it allows simulation of patient characteristics beyond the limits of inclusion and exclusion criteria in historical protocols. Conclusion: Both methods, discrete resampling and multivariate distribution generate realistic pools of virtual patients. However the use of a multivariate distribution enable more flexible simulation scenarios since it is not necessarily bound to the existing covariate combinations in the available clinical data sets.
AB - Purpose: Clinical Trial Simulations (CTS) are a valuable tool for decision-making during drug development. However, to obtain realistic simulation scenarios, the patients included in the CTS must be representative of the target population. This is particularly important when covariate effects exist that may affect the outcome of a trial. The objective of our investigation was to evaluate and compare CTS results using re-sampling from a population pool and multivariate distributions to simulate patient covariates. Methods: COPD was selected as paradigm disease for the purposes of our analysis, FEV1 was used as response measure and the effects of a hypothetical intervention were evaluated in different populations in order to assess the predictive performance of the two methods. Results: Our results show that the multivariate distribution method produces realistic covariate correlations, comparable to the real population. Moreover, it allows simulation of patient characteristics beyond the limits of inclusion and exclusion criteria in historical protocols. Conclusion: Both methods, discrete resampling and multivariate distribution generate realistic pools of virtual patients. However the use of a multivariate distribution enable more flexible simulation scenarios since it is not necessarily bound to the existing covariate combinations in the available clinical data sets.
KW - clinical trial simulations
KW - covariate effect
KW - demographics
KW - drug development
KW - inclusion and exclusion criteria
KW - multivariate distribution
KW - re-sampling
UR - http://www.scopus.com/inward/record.url?scp=84942295290&partnerID=8YFLogxK
U2 - 10.1007/s11095-015-1699-x
DO - 10.1007/s11095-015-1699-x
M3 - Article
C2 - 25994981
AN - SCOPUS:84942295290
SN - 0724-8741
VL - 32
SP - 3228
EP - 3237
JO - Pharmaceutical Research
JF - Pharmaceutical Research
IS - 10
ER -